HONG-KONG-SCIENCE
Hong Kong is open to all and Hong Kong Science and Technology Parks Corporation (HKSTP) is ramping up its seventh Elevator Pitch Competition (EPiC 2023) by unveiling its 50 Grand Finale semi-finalists, selected from 618 entries and 55 economies across the world.
EPiC 2023 -- backed by innovation-driven partners Cathay, HSBC, MTR Lab, plus world-leading accelerator Plug & Play -- is the city’s most eagerly anticipated pitch event each year and will take place on 28 April 2023 (Friday) at the summit of Hong Kong’s tallest building, the International Commerce Centre. The annual event is a unique, worldwide competition for mid to late-stage startups in the FinTech and PropTech sectors who seek to expand their footprints into Asia and beyond, while leveraging Hong Kong’s biggest innovation ecosystem at HKSTP.
EPiC provides the best available platform for startups to make real business impact through connections with the Science Park network of 1,000+ investors and 300+ corporate partners.
This year, three quarters of the entries are from overseas, with the proportion of overseas contestants and the number of economies participating hitting a record high since 2016. A total of 50 contestants representing 14 different economies entered the semi-final round.
All 50 semi-finalists have a golden opportunity to be considered for direct investment of up to US$5 million from the HKSTP Venture Fund, as well as market expansion support across Asia and beyond, plus the chance to win a cash prize of US$90,000 if crowned overall champion.
Albert Wong, CEO, HKSTP, said: “EPiC is an iconic mega event that has hit global scale, as record turnout from international startups further demonstrates Hong Kong’s advantages as an international I&T hub. Hong Kong is diversified, vibrant and attracts the very best entrepreneurs, investors and corporate innovators. Grow fast and go beyond is the theme for EPiC this year, and we welcome talents from around the world to explore Hong Kong’s unlimited investment and innovation opportunities.”
The EPiC Grand Finale on 28 April will be hosted at Hong Kong’s iconic Sky 100 venue atop Hong Kong’s tallest building, the International Commerce Centre. The 50 competing teams will pitch their world-changing ideas to a judging panel of renowned investors, entrepreneurs, and business leaders. The actual pitch will comprise of a 60-second elevator ride as participants compete for the title of overall EPiC Champion.
To propel EPiC to the broader public, HKSTP has launched for the first time, the "My Favourite Pitcher" public poll, which is open to all to vote for their favourite pitch video from the shortlisted 50 semi-finalists. The poll is now available at EPiC polling website (epic-voting.hkstp.org) and lasts until 28 April 2023 1pm (HKT). The semi-finalist with the highest number of votes will win the cash prize of US$10,000, plus 200,000 Asia Miles sponsored by Cathay.
HKSTP will also kick off the exclusive Immersion Programme for semi-finalists to experience Hong Kong’s I&T ecosystem first-hand and unlock business opportunities through educational talks, business matching and networking with leading corporate partners and investors across the HKSTP ecosystem.
Contestants Breakdown:
Category |
No. of applicants |
PropTech |
266 (43%) |
FinTech |
352 (57%) |
Headquarter |
No. of applicants |
Overseas |
465 (75%) |
Hong Kong |
153 (25%) |
A record high proportion of overseas contestants and economies participation since 2016.
EPiC activities:
Now until 28 April 2023, 1pm (HKT)
"My Favourite Pitcher" Public Polling
- The top 50 semi-finalists' pitching videos is open for public online voting
- The semi-finalist with the highest number of votes will be crowned EPiC 2023's "My Favourite Pitcher" and win the cash prize of US$10,000 plus 200,000 Asia Miles sponsored by Cathay
25 – 26 April 2023
"Grow Beyond Hong Kong" Immersion Programme
- An exclusive 2-day programme for EPiC 2023 semi-finalists to experience HKSTP’s innovation ecosystem.
- Participants will unlock growth opportunities through educational talks, business matching and networking with leading corporate partners and investors in our ecosystem.
28 April 2023
EPiC 2023 Grand Finale
- Venue: Sky100 Hong Kong Observation Deck
- Top 50 Semi-Finalists will pitch their ideas within a 60-second elevator ride
- Top 10 Finalists will pitch their innovation ideas on stage to renowned investors, entrepreneurs, and business leaders
- All 50 semi-finalists have the golden opportunities to be considered for direct investment of up to US$5 million from the HKSTP Venture Fund, plus the chance to win a cash prize of US$90,000 if crowned overall champion.
For more information on EPiC 2023, please visit: https://epic.hkstp.org/
For full list of the 50 semi-finalists see appendix below.
About Hong Kong Science and Technology Parks Corporation
Hong Kong Science and Technology Parks Corporation (HKSTP) has for over 20 years committed to building up Hong Kong as an international innovation and technology hub to propel success for local and global pioneers today and tomorrow. HKSTP has established a thriving I&T ecosystem that is home to two unicorns and Hong Kong’s leading R&D hub with over 12,000 research professionals and over 1,200 technology companies focused on healthtech, AI and robotics, fintech and smart city technologies.
Established in 2001, we attract and nurture talent, accelerate and commercialise innovation and technology for entrepreneurs on their journey of growth in Hong Kong, to the Greater Bay Area, Asia and beyond. Our growing innovation ecosystem is built around our key locations of Hong Kong Science Park in Shatin, InnoCentre in Kowloon Tong and three modern INNOPARKs in Tai Po, Tseung Kwan O and Yuen Long. The three INNOPARKs are realising a vision of new industrialisation for Hong Kong. The goal is sectors like advanced manufacturing, electronics and biotechnology are being reimagined for a new generation of industry.
Through our infrastructure, services, expertise and network of partnerships, HKSTP will help establish innovation and technology as a pillar of growth for Hong Kong, while reinforcing Hong Kong’s international I&T hub status as a launchpad for global growth at the heart of the GBA innovation powerhouse.
More information about HKSTP is available at www.hkstp.org.
APPENDIX:
50 semi-finalists for the Grand Finale of EPiC 2023, with 26 from FinTech and 24 from PropTech:
FinTech
Company Name (in alphabetical order) |
Headquarter |
|
1 |
AlgoBot Limited |
Hong Kong SAR China |
2 |
Amuro Limited |
Hong Kong SAR China |
3 |
Canvasland Limited |
Hong Kong SAR China |
4 |
Deland Labs |
Singapore |
5 |
Doconomy |
Sweden |
6 |
Dowsure |
Mainland China |
7 |
Endangered Wildlife OÜ |
Estonia |
8 |
FedML, Inc. |
United States |
9 |
FinCrime Dynamics |
United Kingdom |
10 |
Finema |
Thailand |
11 |
FINGREEN AI |
France |
12 |
PFY Healthcare Technology |
Mainland China |
13 |
Homebase |
Vietnam |
14 |
Leapstack |
Vietnam |
15 |
Miotech |
Mainland China |
16 |
Prometheus Technologies |
United States |
17 |
Redkik |
United States |
18 |
Revix |
United Kingdom |
19 |
Sensor data |
Mainland China |
20 |
Health Exchange Technology Service Group |
Mainland China |
21 |
Speedlegal |
United States |
22 |
Taos Technology LLC |
United States |
23 |
Ultipa |
Mainland China |
24 |
VoiceAI Technologies |
Mainland China |
25 |
Vymo |
United States |
26 |
Wequity |
Belgium |
PropTech
Company Name (in alphabetical order) |
Headquarter |
|
1 |
Archifiction |
Mainland China |
2 |
Bridge5 Asia |
Singapore |
3 |
Collov, Inc |
United States |
4 |
Dfocus |
Mainland China |
5 |
Doratoon |
Singapore |
6 |
EGG Lighting |
United Kingdom |
7 |
Firefly Dimension, Inc. |
United States |
8 |
FLX Solutions |
United States |
9 |
I2Cool Limited |
Hong Kong SAR China |
10 |
IronYun |
United States |
11 |
Kodifly Limited |
Hong Kong SAR China |
12 |
Layer Construction, Inc. |
United States |
13 |
Llewellyn and Partners Company Limited |
Hong Kong SAR China |
14 |
Mimicrete |
United Kingdom |
15 |
PassiveLogic |
United States |
16 |
Photinique Limited |
Hong Kong SAR China |
17 |
Rootie |
Israel |
18 |
SKYLAND INNOVATION COMPANY LIMITED |
Hong Kong SAR China |
19 |
Structure Pal |
Israel |
20 |
Swiss AI |
Switzerland |
21 |
Tensorflight, Inc. |
United States |
22 |
Umi Coating New Material Technology Co., Limited |
Hong Kong SAR China |
23 |
Visionaries 777 |
Hong Kong SAR China |
24 |
VoltSafe Inc. |
Canada |
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230324005001/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical Group Enters the Thai Market through Partnership with BLEZ14.11.2025 13:47:00 CET | Press release
-- Advancing Its Overseas Growth Strategy to Expand Japanese-Quality Aesthetic Medicine Across Asia Following Singapore -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that it has entered into a Consulting Agreement with BLEZ ASIA Co., Ltd. (Headquarters: Bangkok, Thailand; CEO: Naoki Iida; “BLEZ”), which operates more than 20 pharmacies and clinics in Thailand and is widely trusted by both Japanese expatriates and local patients. The partnership is a key component of SBC’s broader Asia strategy and represents a significant step toward full-scale entry into the rapidly growing Thai aesthetic medicine market. Under the agreement, SBC will provide comprehensive management support to a new clinic focused primarily on dermatological treatments such as pigmentation and spot removal, which BLEZ is preparing to open in
SBC Medical Group Holdings Announces Third Quarter 2025 Financial Results14.11.2025 13:00:00 CET | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced its financial results for the third quarter of fiscal year 2025 (three months ended September 30, 2025) and for the third quarter cumulative of fiscal year 2025 (Year-to-Date 2025, nine months ended September 30, 2025) Third Quarter 2025 Highlights Total revenues were $43 million, representing an 18% year-over-year decrease. Income from operations was $16 million, representing a 15% year-over-year increase. Net Income attributable to SBC Medical Group was $13 million , representing an 353% year-over-year increase. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.12 for the three months ended September 30, 2025, compared to $0.03 in the same period of 2024. EBITDA1, which
Ant Group Chairman Eric Jing Outlines Strategy for Inclusive AI, Collaboration on Tokenised Settlement14.11.2025 11:15:00 CET | Press release
AI-as-a-Service applications will make AI virtual CFO and COO for SMEsPublic-private collaboration in regulatory sandboxes help to provide clarity and certainty when it comes to new technology like tokenisation and AI Eric Jing, Chairman of Ant Group, said the company's focus is on putting new payment and operation tools powered by AI and tokenisation technology in the hands of SMEs, to fully embrace the next wave of global productivity revolution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251114239737/en/ Ant Group Chairman Eric Jing (second from right) shares insights during a panel discussion titled “Steering the Global Future” during the Singapore FinTech Festival on November 14, 2025. “We are passionate about using frontier technology to support SMEs and the use of AI will really uplift inclusion,” Jing said during a panel discussion titled “Steering the Global Future” during the Singapore FinTech Festival on Novem
Allianz Achieves Record Results and Expects a Full-Year Operating Profit of at Least 17 Billion Euros14.11.2025 07:16:00 CET | Press release
3Q 2025 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251113803211/en/ Oliver Bäte, Chief Executive Officer of Allianz SE Double-digit growth in operating profit and shareholders’ core net incomeTotal business volume rises 5.21 percent with contributions from all segments Operating profit increases 12.6 percent to 4.4 billion euros, with particular strong contribution from the Property-Casualty segment Shareholders’ core net income advances by 12.7 percent and reaches 2.9 billion euros 9M 2025 Continued strong and diversified growth across our businessesand record operating profitTotal business volume rises 8.5 1 percent and reaches 141.2 billion euros with contributions from all segments Operating profit increases 10.4 percent to 13.1 billion euros, our highest nine-month operating profit ever, reaching 82 percent of our full-year outlook midpoint Shareholders’ core net income advances 10.5 percent to 8.4 billion euros. Ad
Galderma Completes Successful Placement of CHF 175 Million Bond14.11.2025 07:00:00 CET | Press release
NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE LAW OR REGULATION. Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced the successful placement of a single-tranche CHF 175 million Swiss franc-denominated bond. The bond has a maturity of 5 years and carries a fixed-rate annual coupon of 0.9425%. Net proceeds from the transaction will be used to partially refinance Galderma’s existing bank term loan issued at its initial public offering (IPO) in March 2024, as well as for general corporate purposes. This marks the company’s third CHF-bond issuance since listing. The new bond will be listed on the SIX Swiss Exchange, with the settlement date expected on December 10, 2025. BNP Paribas and UBS jointly led the transaction. Galderma is rated BBB (stable outlook) by Fitch. The same rating is also expected to be assigned to the new bond. The successful issuance is leverage-ne
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
